The prevalence of hypertension, valve calcification and left ventricular hypertrophy and geometry in peritoneal dialysis patients

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 431-437

  Yilmaz, Murvet ^a   Unsal, Abdulkadir ^b   Oztekin, Erkan ^b   Kesmezacar, Ozgu ^c   Harmankaya Kaptanogullari, Ozlem ^a   Eren, Nezaket ^b  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hypertension; Left ventricular hypertrophy; Peritoneal dialysis; Valve calcification

Indexed keywords

SERUM ALBUMIN;

ADULT; AORTA VALVE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CALCIFICATION; DIABETIC NEPHROPATHY; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; GLOMERULOPATHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE CALCIFICATION; HUMAN; HYPERTENSION; HYPERTENSIVE NEPHROSCLEROSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NEPHROSCLEROSIS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; SODIUM RESTRICTION;

ADULT; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MITRAL VALVE; PERITONEAL DIALYSIS; PREVALENCE;

EID: 84861835777     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000336946     Document Type: Article

References (47)

1. US Renal Data System: USRDS 2010 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
2. Serdengeçti K, Suleymanlar G, Altiparmak MR, Seyahi N: Registry of Nephrology, Dialysis and Transplantation in Turkey Y Registry 2009. Istanbul, Turkish Society of Nephrology, 2010.
3. Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, Bellanuova I, Giacone G, Malatino LS, Zoccali C: Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 2004; 43: 479-484.
4. Mazzaferro S, Coen G, Bandini S, Borgatti PP, Ciaccheri M, Diacinti D, Ferranti E, Lusenti T, Mancini G, Monducci I, et al: Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8: 335-340.
5. Tarrass F, Benjelloun M, Zamd M, Medkouri G, Hachim K, Benghanem MG, Ramdani B: Heart valve calcifications in patients with end-stage renal disease: Analysis for risk factors. Nephrology (Carlton) 2006; 11: 494-496.
6. Raine AE: Acquired aortic stenosis in dialysis patients. Nephron 1994; 68: 159-168.
7. Guérin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021.
8. Wang AY, Ho SS, Wang M, Liu EK, Ho S, Li PK, Lui SF, Sanderson JE: Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005; 165: 327-332.
9. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401.
10. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remédio F, Ribeiro F: Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037-2040.
11. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-2767.
12. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
13. Toprak A, Koc M, Tezcan H, Ozener IC, Akoglu E, Oktay A: Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: An echocardiographic study. Nephrol Dial Transplant 2003; 18: 2128-2133.
14. Ates K: Salt and water in PD: The Turkish contribution. Perit Dial Int 2008; 28: 224-228.
15. de Simone G: Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421-2427.
16. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB: Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996; 28: 751-756.
17. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608.
18. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
19. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C: Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-878.
20. Ozkahya M, Ok E, Cirit M, Aydin S, Akçiçek F, Başçi A, Dorhout Mees EJ: Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-1493.
21. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-1285.
22. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010; 5: 805-813.
23. Nitta K, Akiba T, Uchida K, Otsubo S, Otsubo Y, Takei T, Ogawa T, Yumura W, Kabaya T, Nihei H: Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 2004; 27: 47-52.
24. Ozkahya M, Töz H, Unsal A, Ozerkan F, Asci G, Gürgün C, Akçiçek F, Mees EJ: Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor. Am J Kidney Dis 1999; 34: 218-221.
25. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660.
26. Gunal AI, Duman S, Ozkahya M, Töz H, Asçi G, Akcicek F, Basci A: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-593.
27. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
28. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
29. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
30. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
31. Ateş K, Nergizoǧlu G, Keven K, Sen A, Kutlay S, Ertürk S, Duman N, Karatan O, Ertuǧ AE: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767-776.
32. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC: Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17: 1661-1666.
33. Covic A, Mardare NG, Ardeleanu S, Prisada O, Gusbeth-Tatomir P, Goldsmith DJ: Serial echocardiographic changes in patients on hemodialysis: An evaluation of guideline implementation. J Nephrol 2006; 19: 783-793.
34. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, Giacone G, Cottini E, Tripepi G, Malatino LS, Zoccali C: Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1459-1464.
35. Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, Sturani A, Quarello F, Boero R, Bruno M, Dadone C, Favazza A, Scanziani R, Tommasi A, Giangrande A: Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536-1540.
36. Asci G, Ozkahya M, Duman S, Toz H, Erten S, Ok E: Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int 2006; 26: 85-88.
37. Hüting J: Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis. Chest 1994; 105: 383-388.
38. Rufino M, García S, Jiménez A, Alvarez A, Miquel R, Delgado P, Marrero D, Torres A, Hernández D, Lorenzo V: Heart valve calcification and calcium x phosphorus product in hemodialysis patients: Analysis of optimum values for its prevention. Kidney Int Suppl 2003; 85: 115-118.
39. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987;ii:875-877.
40. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P: Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 1996; 45: 104-110.
41. Yoshida M, Takamatsu J, Yoshida S, Tanaka K, Takeda K, Higashi H, Kitaoka H, Ohsawa N: Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of diabetes-specific complications. Horm Metab Res 1999; 31: 558-563.
42. Strózecki P, Odrowaz-Sypniewska G, Manitius J: Cardiac valve calcifications and left ventricular hypertrophy in hemodialysis patients. Ren Fail 2005; 27: 733-738.
43. Paoletti E, Cassottana P, Bellino D, Specchia C, Messa P, Cannella G: Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002; 40: 728-736.
44. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS: Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 2000;20: 396-401.
45. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in endstage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
46. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001; 12: 1927-1936.
47. Wang AY: Vascular and other tissue calcification in peritoneal dialysis patients. Perit Dial Int 2009; 29: 9-14.